Azienda Unita Sanitaria Locale Di Reggio Emilia

At Azienda Unita Sanitaria Locale Di Reggio Emilia, research in neoplasms includes studies focused on prostate cancer and breast cancer. These trials are designed to evaluate whether new treatment strategies can better control disease progression and improve outcomes for patients with advanced or recurrent cancer.

• Biochemically recurrent prostate cancer
• Locally-advanced unresectable or metastatic breast cancer
• Testing new treatment combinations for improved cancer control

The oncology unit is also contributing to research aimed at comparing treatment effectiveness and supporting more personalized care for people with difficult-to-treat cancers.

Clinical research in cardiovascular diseases at this hospital includes work on preventing serious vascular events after acute ischemic stroke and high-risk transient ischemic attack. The main goal is to assess whether a new therapy can reduce the risk of another stroke and improve protection for patients at high risk.

• Acute ischemic stroke and high-risk transient ischemic attack
• Evaluating prevention of recurrent ischemic events
• Improving treatment effectiveness after a recent stroke

This area reflects a strong interest in better secondary prevention and safer long-term care for people with cerebrovascular disease.

Research in eye diseases includes studies of uveitic macular edema, a vision-threatening condition linked to inflammation inside the eye. These trials aim to determine whether new treatments can improve visual function and reduce disease impact compared with sham treatment.

• Uveitic macular edema
• Assessing improvement in visual acuity
• Testing a therapy for inflammatory eye disease

The focus is on preserving sight and offering better options for patients living with chronic ocular inflammation.

The site also participates in research related to cell physiological phenomena, supporting studies that explore how disease behaves at a biological level and how targeted treatments may work in specific patient groups. This type of research helps connect laboratory understanding with practical clinical care.

• Targeted treatment response in cancer and other diseases
• Understanding disease behavior at the cellular level
• Supporting development of more precise therapies

At Azienda Unita Sanitaria Locale Di Reggio Emilia, this broader scientific focus complements the clinical work in oncology, stroke prevention, and ophthalmology.